HSBC Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $839M | Sell |
3,860,492
-204,488
| -5% | -$45.4M | 0.44% | 34 |
|
|
2025
Q4 | $930M | Buy |
4,064,980
+115,544
| +3% | +$26.3M | 0.47% | 27 |
|
|
2025
Q3 | $913M | Sell |
3,949,436
-174,873
| -4% | -$35.6M | 0.5% | 27 |
|
|
2025
Q2 | $765M | Sell |
4,124,309
-311,339
| -7% | -$57.9M | 0.46% | 33 |
|
|
2025
Q1 | $927M | Sell |
4,435,648
-113,120
| -2% | -$22M | 0.57% | 27 |
|
|
2024
Q4 | $807M | Buy |
4,548,768
+155,747
| +4% | +$28.6M | 0.47% | 33 |
|
|
2024
Q3 | $866M | Sell |
4,393,021
-480,141
| -10% | -$89.6M | 0.5% | 32 |
|
|
2024
Q2 | $834M | Buy |
4,873,162
+204,025
| +4% | +$33.8M | 0.51% | 31 |
|
|
2024
Q1 | $850M | Buy |
4,669,137
+530,023
| +13% | +$91.3M | 0.58% | 26 |
|
|
2023
Q4 | $641M | Buy |
4,139,114
+311,349
| +8% | +$45.4M | 0.56% | 26 |
|
|
2023
Q3 | $571M | Buy |
3,827,765
+116,861
| +3% | +$17.2M | 0.59% | 27 |
|
|
2023
Q2 | $500M | Buy |
3,710,904
+830,964
| +29% | +$122M | 0.51% | 30 |
|
|
2023
Q1 | $459M | Sell |
2,879,940
-159,780
| -5% | -$24.4M | 0.55% | 25 |
|
|
2022
Q4 | $490M | Buy |
3,039,720
+987,769
| +48% | +$151M | 0.56% | 25 |
|
|
2022
Q3 | $276M | Buy |
2,051,951
+187,441
| +10% | +$26.9M | 0.45% | 33 |
|
|
2022
Q2 | $287M | Buy |
1,864,510
+297,626
| +19% | +$45.5M | 0.4% | 43 |
|
|
2022
Q1 | $255M | Sell |
1,566,884
-252,799
| -14% | -$36.7M | 0.31% | 49 |
|
|
2021
Q4 | $247M | Sell |
1,819,683
-225,975
| -11% | -$26.7M | 0.23% | 71 |
|
|
2021
Q3 | $222M | Sell |
2,045,658
-471,866
| -19% | -$53.9M | 0.22% | 75 |
|
|
2021
Q2 | $283M | Sell |
2,517,524
-855,683
| -25% | -$96.4M | 0.3% | 58 |
|
|
2021
Q1 | $365M | Buy |
3,373,207
+738,043
| +28% | +$78.9M | 0.43% | 40 |
|
|
2020
Q4 | $280M | Buy |
2,635,164
+327,293
| +14% | +$31.5M | 0.37% | 46 |
|
|
2020
Q3 | $202M | Buy |
2,307,871
+609,962
| +36% | +$57.4M | 0.32% | 48 |
|
|
2020
Q2 | $167M | Buy |
1,697,909
+182,916
| +12% | +$16.1M | 0.32% | 56 |
|
|
2020
Q1 | $115M | Sell |
1,514,993
-27,575
| -2% | -$2.35M | 0.27% | 71 |
|
|
2019
Q4 | $137M | Sell |
1,542,568
-1,619,334
| -51% | -$134M | 0.24% | 72 |
|
|
2019
Q3 | $239M | Buy |
3,161,902
+1,278,348
| +68% | +$87.6M | 0.45% | 30 |
|
|
2019
Q2 | $137M | Buy |
1,883,554
+506,758
| +37% | +$39.8M | 0.26% | 71 |
|
|
2019
Q1 | $111M | Sell |
1,376,796
-201,861
| -13% | -$16.5M | 0.2% | 106 |
|
|
2018
Q4 | $146M | Buy |
1,578,657
+35,650
| +2% | +$3.14M | 0.27% | 67 |
|
|
2018
Q3 | $146M | Sell |
1,543,007
-471,864
| -23% | -$44.7M | 0.23% | 78 |
|
|
2018
Q2 | $187M | Sell |
2,014,871
-1,603,100
| -44% | -$157M | 0.33% | 50 |
|
|
2018
Q1 | $342M | Sell |
3,617,971
-1,030,611
| -22% | -$113M | 0.51% | 27 |
|
|
2017
Q4 | $450M | Buy |
4,648,582
+1,911,596
| +70% | +$180M | 0.65% | 31 |
|
|
2017
Q3 | $243M | Buy |
2,736,986
+620,146
| +29% | +$47.2M | 0.39% | 47 |
|
|
2017
Q2 | $153M | Buy |
2,116,840
+222,884
| +12% | +$15M | 0.28% | 59 |
|
|
2017
Q1 | $123M | Sell |
1,893,956
-261,576
| -12% | -$16.4M | 0.26% | 68 |
|
|
2016
Q4 | $135M | Buy |
2,155,532
+324,761
| +18% | +$19.8M | 0.31% | 60 |
|
|
2016
Q3 | $115M | Sell |
1,830,771
-81,538
| -4% | -$5.28M | 0.29% | 72 |
|
|
2016
Q2 | $118M | Sell |
1,912,309
-92,061
| -5% | -$5.61M | 0.33% | 65 |
|
|
2016
Q1 | $114M | Sell |
2,004,370
-330,855
| -14% | -$18.4M | 0.32% | 68 |
|
|
2015
Q4 | $139M | Sell |
2,335,225
-242,727
| -9% | -$14M | 0.33% | 56 |
|
|
2015
Q3 | $140M | Sell |
2,577,952
-502,094
| -16% | -$32.7M | 0.35% | 60 |
|
|
2015
Q2 | $207M | Sell |
3,080,046
-1,180,543
| -28% | -$77.1M | 0.42% | 43 |
|
|
2015
Q1 | $249M | Buy |
4,260,589
+495,033
| +13% | +$29.9M | 0.48% | 39 |
|
|
2014
Q4 | $247M | Buy |
3,765,556
+177,975
| +5% | +$11.2M | 0.51% | 38 |
|
|
2014
Q3 | $207M | Sell |
3,587,581
-296,517
| -8% | -$16.5M | 0.43% | 44 |
|
|
2014
Q2 | $219M | Sell |
3,884,098
-393,197
| -9% | -$20.6M | 0.47% | 39 |
|
|
2014
Q1 | $220M | Buy |
4,277,295
+212,916
| +5% | +$10.8M | 0.53% | 37 |
|
|
2013
Q4 | $215M | Buy |
4,064,379
+391,644
| +11% | +$19.2M | 0.56% | 28 |
|
|
2013
Q3 | $164M | Sell |
3,672,735
-44,962
| -1% | -$1.99M | 0.45% | 40 |
|
|
2013
Q2 | $154M | Buy |
+3,717,697
| New | +$163M | 0.46% | 41 |
|
Other funds holding ABBV
VCM
VPM
HSBC Holdings's ABBV Position: Q1 2026 in Review
HSBC Holdings reduced its AbbVie (ABBV) stake by 5% in Q1 2026, selling an estimated $45.4M and leaving 3,860,492 shares worth $839M. The position accounts for 0.44% of the portfolio, ranked #34.
HSBC Holdings first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $930M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- HSBC Holdings held 3,860,492 shares of AbbVie worth $839M as of Q1 2026.
- HSBC Holdings sold 204,488 AbbVie shares in Q1 2026, an estimated $45.4M.
- AbbVie made up 0.44% of HSBC Holdings's portfolio in Q1 2026, its #34 holding.
- HSBC Holdings first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's AbbVie position peaked at $930M in Q4 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.